The light your cells can actually use

At some point, most people who train consistently notice the same thing: effort stays constant, but the body takes longer to bounce back. Sleep, nutrition, and movement are all accounted for — yet something in the recovery signal feels muted.

One answer may lie not in what you're doing, but in what you're missing. Specifically, light — at particular wavelengths that the body knows how to use.

Photobiomodulation (PBM) is the deliberate application of red and near-infrared wavelengths to interact directly with cellular biology. It is not passive sunbathing. It is a targeted input, and the distinction matters.

In Regeneration by Design, Professor Paul Lee frames this within his Physics pillar — the idea that physical energies, including light, load, and movement, are among the most underused tools in how the body repairs itself. Light at the right wavelength, delivered at the right dose, may support that process from the inside out.

This article explains how that mechanism works, and what a practical, research-informed weekly protocol might look like.

How photons reach your mitochondria

Inside every cell, the mitochondria run a continuous energy-production line. At the end of that line sits an enzyme called cytochrome c oxidase (CCO) — Complex IV of the electron transport chain, and the point at which electrons are finally handed off to oxygen. It is also the primary site at which red and near-infrared photons, in the 630–850 nm window, appear to have their effect.

The reason that window matters is partly one of physics. Shorter wavelengths, including blue and UV light, are absorbed or scattered before reaching significant tissue depth. Red light (around 630–660 nm) penetrates to the dermal and superficial layers; near-infrared (around 810–850 nm) travels deeper still, reaching muscle, joint, and connective tissue. At the right wavelength, photons can reach CCO directly.

What happens next is the core of the leading mechanistic hypothesis, supported by multiple 2024–2026 reviews and a 2023 National Institute on Ageing workshop. Under physiological stress, nitric oxide (NO) binds to CCO and partly inhibits it — effectively throttling the energy line. Specific red and NIR wavelengths appear to break that bond, releasing the NO and allowing CCO to resume full electron transport. The restored flow raises the electrochemical gradient across the inner mitochondrial membrane, driving greater ATP synthesis. The freed NO simultaneously signals nearby blood vessels to dilate, improving local circulation. Downstream, reactive oxygen species and cytokine balance may also shift, with anti-inflammatory effects observed in cell and immune studies.

This appears to be a switch-restoring mechanism rather than an artificial stimulus imposed on healthy tissue. Multiple reviews note that null or marginal results tend to cluster in already-trained cohorts with low oxidative stress — suggesting the benefit may scale with the degree of cellular deficit already present. That context shapes everything about how a protocol should be structured.

What the research actually shows

Skin and collagen research offers some of the cleaner data points. A 2023 clinical study using red light at 630 nm, twice weekly for three months, recorded progressive improvements in wrinkle depth, skin firmness, elasticity, and dermis density across all participants. A 2026 review of clinical trials identified approximately 10–12 minutes per session, twice per week, as the dose pattern most consistently associated with measurable collagen improvements — a practical anchor when assessing any red-light protocol.

Exercise recovery evidence is building. A 2025 randomised controlled trial found that photobiomodulation applied to the quadriceps immediately after exhausting cycling significantly reduced blood lactate at both 10 and 20 minutes post-exercise, and improved both mean and peak power output on a subsequent test, versus placebo. A 2025 systematic review of whole-body PBM for performance and recovery — the format closest to full-panel devices — found a broadly supportive but mixed picture, with effect sizes varying considerably across populations and device types.

For musculoskeletal comfort, studies in rotator-cuff pain and peripheral neuropathy suggest PBM may support recovery and ease in joints and peripheral tissue. A 2025 international expert consensus placed the evidence as strongest for neuropathy, wound healing, and alopecia — rather than general muscle fatigue — which is worth bearing in mind when setting expectations.

At the systemic level, a 2026 study of 56 participants found that distinct wavelength-and-dose combinations produced different effects on HDL, insulin, and ferritin markers. These are early signals from a single study, not a clinical prescription — but they reinforce the idea that the specific parameters of a protocol may matter more than simply exposing the body to any red or near-infrared light.

Across all these outcome areas, one limitation runs through the data: results are genuinely difficult to compare because device outputs, application distances, and session durations vary widely between studies. Null or equivocal findings appear more often in already-trained individuals with low physiological stress — a pattern the mechanistic story would predict, and a reason to hold all positive findings at their real evidence stage rather than as guaranteed outcomes.

Wavelength and dose: why 660 nm and 850 nm

Two numbers appear consistently across photobiomodulation research: 660 nm and 850 nm. They are not arbitrary choices — they follow directly from the tissue-depth relationship described in the mechanistic story above.

Red light in the 630–660 nm range penetrates primarily to the dermal layers of the skin. That is the zone relevant to collagen synthesis, surface repair, and the skin-quality outcomes seen in the twice-weekly trials discussed earlier. Near-infrared at 810–850 nm travels considerably further, reaching muscle, tendon, joint capsule, and deeper connective tissue — the territory relevant to recovery and musculoskeletal comfort.

Dose matters as much as wavelength. The standard metric is joules per cm² (J/cm²) — total light energy delivered per unit of skin area — calculated by multiplying device irradiance (mW/cm²) by exposure time in seconds, then dividing by 1,000. Research points to roughly 2–10 J/cm² for superficial targets and 10–50 J/cm² for deeper tissue. Beyond approximately 50–60 J/cm² per session, the biphasic dose-response — also called the Arndt-Schulz law — suggests that additional energy begins to reduce rather than extend the benefit. More is not always more; there is a productive window, and exceeding it may work against the cellular response.

The CellLight™ system in the Regen PhD Pod — the brand's own wellness device, and worth naming plainly as such — is built around these same two wavelengths for the same reason: 660 nm directed to surface tissue, 850 nm calibrated for depth. The logic is the mechanistic one, not a proprietary claim.

One practical timing note: red and near-infrared wavelengths in this range do not appear to suppress melatonin the way blue light does, so evening use is unlikely to disturb sleep for most people. High-intensity NIR may feel mildly energising for some, in which case a morning or midday session is a sensible adjustment.

A practical weekly protocol

Building a PBM habit follows a simple two-phase logic — begin with enough frequency to accumulate an adaptive stimulus, then pull back once the body has adjusted.

Loading phase (weeks 1–8)

• 3–5 sessions per week
• 10–20 minutes per session
• Distance: 6–12 inches from the device panel

Maintenance phase (ongoing)

• 1–2 sessions per week
• Same session length

The 10–20 minute window is not a conservative guess — it maps to the dose range that clinical trials have used to produce measurable outcomes, and it respects the biphasic ceiling discussed in the previous section. Running a session for 40 minutes does not double the benefit; it may reduce it.

Three variables are worth adjusting to your own situation. First, tissue depth: if the primary goal is muscle recovery or joint comfort, lean towards NIR-dominant sessions; if it is collagen and skin quality, red at 660 nm is the relevant wavelength. Second, timing: post-exercise is a reasonable window for recovery use, given the evidence that blood lactate clears faster with prompt application. Morning or early afternoon suits those who notice an energising quality to high-intensity NIR. Evening works well for skin-focused use, since red and near-infrared wavelengths are not associated with melatonin suppression. Third, individual response: two people at the same frequency and duration may report different results depending on baseline cellular stress, skin tone, and tissue density.

Standardised dosimetry across the field is still being established — the 2025 international expert consensus named this explicitly as a limitation. In the Regen PhD framing, that is less a caveat than an invitation: the protocol above is a well-reasoned starting structure, but the most useful data point is your own response over four to six weeks. Adjust from there.

Where PBM fits in your regeneration system

Zoom out from the cellular detail and PBM lands squarely in what Professor Paul Lee calls the Physics pillar of Regeneration by Design — the deliberate use of a physical energy to shape the body's repair environment. But nothing in that framework operates in isolation. Light acts on mitochondria (Physics), which produce ATP and modulate ROS (Chemistry), which in turn feeds recovery quality, immune tone, and sleep architecture (Biology). Three pillars engaged by a single input; the interdependence is built into the mechanism, not added as an afterthought.

That logic runs through the Regen PhD Pod's design: the CellLight™ system layers PBM alongside other Physics-pillar inputs within a single session, on the premise that compatible stimuli, timed well, compound each other's effects rather than competing for the same recovery bandwidth.

This week's starting point. Choose three sessions and fix them to the same time of day — post-exercise for recovery, morning for energy, evening for skin-focused use. Run 10–15 minutes per session. Track one thing: perceived recovery quality, scored simply each morning. Give it four weeks before adjusting frequency up or down.

And here is the specific thing now worth knowing — the one that distinguishes this from any other recovery input. When cellular stress causes nitric oxide to bind to cytochrome c oxidase, that enzyme stalls, and your mitochondria lose access to energy they are fully capable of producing. Red and near-infrared light at the right dose physically breaks that bond. The sessions are not introducing anything foreign; they are releasing a molecular brake that metabolic stress had already applied. Once that distinction is clear, the protocol has a different kind of logic behind it.

1. [1] Effects of photobiomodulation therapy on acute recovery after exhausting cycling exercise. (2025). https://doi.org/10.62617/mcb823 https://doi.org/10.62617/mcb823
2. [2] Light buckets and laser beams: mechanisms and applications of photobiomodulation (PBM) therapy. (2025). https://doi.org/10.1007/s11357-025-01505-z https://doi.org/10.1007/s11357-025-01505-z
3. [3] From light to healing: photobiomodulation therapy in medical disciplines. (2025). https://doi.org/10.1186/s12967-025-07466-3 https://doi.org/10.1186/s12967-025-07466-3
4. [4] Protocol-Dependent Effects of Transcutaneous Blood Systemic Photobiomodulation on Inflammatory, Metabolic, and Hemostatic Markers. (2026). https://doi.org/10.1002/jbio.202500525 https://doi.org/10.1002/jbio.202500525
5. [5] A systematic review on whole-body photobiomodulation for exercise performance and recovery. (2025). https://doi.org/10.1007/s10103-025-04318-w https://doi.org/10.1007/s10103-025-04318-w
6. [6] Immunomodulatory effects of photobiomodulation: a comprehensive review. (2025). https://doi.org/10.1007/s10103-025-04417-8 https://doi.org/10.1007/s10103-025-04417-8
7. [7] Evidence-Based Consensus on the clinical application of Photobiomodulation. (2025). https://doi.org/10.1016/j.jaad.2025.04.031 https://doi.org/10.1016/j.jaad.2025.04.031